Potent σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo

Stroke

Volumn 29, Issue 11, 1998, Pages 2404-2411

  Bhardwaj, Anish ^a,b   Sawada, Masahiko ^a   London, Edythe D ^a   Koehler, Raymond C ^a   Traystman, Richard J ^a   Kirsch, Jeffrey R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Excitotoxicity; Ligands; Microdialysis; Nitric oxide; Rats; Receptors, sigma

Indexed keywords

1 CYCLOPROPYLMETHYL 4 [2 (4 FLUOROPHENYL) 2 OXOETHYL]PIPERIDINE; ARGININE; CITRULLINE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID; N(G) NITROARGININE; NITRIC OXIDE; PENTAZOCINE; SIGMA OPIATE RECEPTOR; SIGMA RECEPTOR LIGAND; AMINO ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; CARBON; DIAGNOSTIC AGENT; DIZOCILPINE MALEATE; DNA BINDING PROTEIN; ENZYME INHIBITOR; INSECT PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYLASPARTIC ACID; NUCLEAR PROTEIN; POLYHEDRIN PROMOTER BINDING PROTEIN, INSECT; POLYHEDRIN PROMOTER-BINDING PROTEIN, INSECT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CORPUS STRIATUM; DRUG EFFECT; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MICRODIALYSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; ANIMAL; BRAIN; BRAIN LEVEL; MALE; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CARBON RADIOISOTOPES; CITRULLINE; DIZOCILPINE MALEATE; DNA-BINDING PROTEINS; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; INSECT PROTEINS; MALE; MICRODIALYSIS; N-METHYLASPARTATE; NITRIC OXIDE; NITROARGININE; NUCLEAR PROTEINS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SIGMA;

EID: 0031787840     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.11.2404     Document Type: Article

References (46)

1. 1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice. Eur J Pharmacol. 1997;328:9-18.
2. Maurice T, Lockhart BP. Neuroprotective and anti-amnesic potentials of sigma receptor ligands. Prog Neuropyschopharmacol Biol Psychiatry. 1997;21:69-102.
3. Bouchard P, Maurice T, St-Pierre S, Privat A, Quirion R, Neuropeptide Y and the calcitonin gene-related peptide attenuate learning impairments induced by MK-801 via a sigma receptor-related mechanism. Eur J Neurosci. 1997;9:2142-2151.
4. Gonzalez-Alvear GM, Werling LL. Sigma receptor regulation of norepinephrine release from rat hippocampal slices. Brain Res. 1995;673: 61-69.
5. 3H]dopamine release from rat striatal slices by sigma receptor ligands. J Pharmacol Exp Ther. 1994;271:212-219.
6. Matsuno K, Matsunaga K, Senda T, Mita S. Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex. J Pharmacol Exp Ther. 1993;265:851-859.
7. Carter C, Benavides J, Legendre P, Vincent JD, Noel F, Thuret F, Lloyd KG, Arbilla S, Zivkovic B, MacKenzie ET. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents, II: evidence for N-methyl-D-aspartate receptor antagonist properties. J Pharmacol Exp Ther. 1988;247: 1222-1232.
8. Lesage As, De Loore KL, Peeters L, Leysen JE. Neuroprotective sigma ligands interfere with the glutamate-activated NOS pathway in hippocampal cell culture. Synapse. 1995;20:156-164.
9. Lysko PG, Feuerstein G. Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: protection by SKF 10,047. Neurosci Lett. 1990;120:217-220.
10. Contreras PC, Gray NM, Ragan DM, Lanthorn TH. BMY-14802 protects against ischemia-induced neuronal damage in the gerbil. Life Sci. 1992; 51:1145-1149.
11. O'Neill M, Caldwell M, Earley B, Canney M, O'Halloran A, Kelly J, Leonard BE, Junien JL. The sigma receptor ligand JO 1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischemia. Eur J Pharmacol. 1995;283:217-225.
12. Takahashi H, Kirsch JR, Hashimoto K, London ED, Koehler RC, Traystman RJ. PPBP [4-phenyl-l-(4-phenylbutyl) peperidine] decreases brain injury after transient focal ischemia in rats. Stroke. 1996;27: 2120-2123.
13. Takahashi H, Kirsch JR, Hashimoto K, London ED, Koehler RC, Traystman RJ. PPBP [4-phenyl-1-(4-phenylbutyl) peperidine], a potent σ-receptor ligand, decreases brain injury after transient focal ischemia in cats. Stroke. 1995;26:1676-1682.
14. Takahashi H, Traystman RJ, Hashimoto K, London ED, Kirsch JR. Postischemic brain injury is affected stereospecifically by pentazocine in rats. Anesth Analg. 1997;85:353-357.
15. 1-binding site. Proc Natl Acad Sci U S A. 1996;93: 8072-8077.
16. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci. 1993;13:2651-2661.
17. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role of nitric oxide. Nature. 1990;347:768-770.
18. Izumi Y, Clifford DB, Zorumski CF. Inhibition of long-term potentiation by NMDA-mediated nitric oxide release. Science. 1992;257:1273-1276.
19. Iadecola C, Pelligrino DA, Moskowitz MA, Lassen N. Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab. 1994;14:175-192.
20. Huang Z, Huang PL, Panahian N, Fishman MC, Moskowitz MA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 1994;265:1883-1885.
21. Zhang J, Dawson VL, Dawson TM, Snyder SH. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science. 1994;263: 687-690.
22. Garthwaite J, Garthwaite G, Palmer RMJ. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol. 1989;172:413-416.
23. Bhardwaj A, Northington FJ, Koehler RC, Steifel T, Hanley DF, Traystman RJ. Adenosine modulates N-methyl-D-aspartate-stimulated hippocampal nitric oxide production in vivo. Stroke. 1995;26:1627-1633.
24. Bhardwaj A, Northington FJ, Ichord RN, Hanley DF, Traystman RJ, Koehler RC. Characterization of ionotropic receptor-mediated nitric oxide production in vivo in rats. Stroke. 1997;28:850-857.
25. Bhardwaj A, Northington FJ, Martin LJ, Hanley DF, Traystman RJ, Koehler RC. Characterization of metabotropic glutamate receptor-mediated nitric oxide production in vivo. J Cereb Blood Flow Metab. 1997;17:153-159.
26. Lockhart BP, Soulard P, Benicourt C, Privat A, Junien J-L. Distinct neuroprotective profiles for σ ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res. 1995;675:110-120
27. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. New York, NY: Academic Press Inc; 1986.
28. Johnson RD, Justice JB. Model studies for brain dialysis. Brain Res Bull. 1983;10:567-571.
29. Van Wylen DGL, Park TS, Rubio R, Berne RM. The effect of local infusion of adenosine and adenosine analogues on local cerebral blood flow. J Cereb Blood Flow Metab. 1989;9:556-562.
30. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH. Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of mammalian CNS together with NADPH diaphorase. Neuron. 1991;7:615-624.
31. Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extracellular concentrations of glutamate and aspartate in the rat hippocampus during transient focal ischemia monitored by intracerebral microdialysis. J Neurochem. 1984;43:1369-1374.
32. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J Neurochem. 1984;42:1-11.
33. Dietrich WD, Alonso O, Halley M, Busto R, Globus MYT. Intraventricular infusion of N-methyl-D-aspartate, II: acute neuronal consequences. Acta Neuropathol (Berl). 1992;84:630-637.
34. Northington FJ, Tobin JR, Koehler RC, Traystman RJ. In vivo production of nitric oxide with NMDA-induced cerebral hyperemia in newborn sheep. Am J Physiol. 1995;38:H215-H222.
35. Vallebuona F, Raiteri M. Extracellular cGMP in the hippocampus of freely moving rats as an index of nitric oxide (NO) synthase activity. J Neurosci. 1994;14:134-139.
36. Benveniste H. Brain microdialysis. J Neurochem. 1989;52:1667-1679
37. Dykstra KH, Hsiao JK, Morrison PF, Bungay PM, Mefford IN, Scully MM, Dedrick RL. Quantitative examination of tissue concentration profiles associated with microdialysis. J Neurochem. 1992;58:931-940.
38. Dietrich WD, Alonso O, Halley M, Busto R, and Globus MYT. Intraventricular infusion of N-methyl-D-aspartate, I: acute blood-brain barrier consequences. Acta Neuropathol (Berl). 1992;84:621-629.
39. Lobner D, Lipton P. σ-Ligands and non-competitive NMDA antagonists inhibit glutamate release during cerebral ischemia. Neurosci Lett. 1990; 117:169-174.
40. ++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons. J Pharmacol Exp Ther. 1995;275:207-214.
41. Willette RN, Lysko PG, Sauermelch CF. A comparison of (+)SF&F 10047 and MK-801 on cortical spreading depression. Brain Res. 1994; 648:347-351.
42. 1-receptors. Eur J Pharmacol. 1994;266:131-138.
43. Picker MJ, Craft RM, Negus SS, Powell KR, Mattox SR, Jones SR, Hargrove BK, Dykstra LA. Intermediate efficacy μ opioids: examination of their morphine-like stimulus effects and response rate-deceasing effects in morphine-tolerant rats. J Pharmacol Exp Ther. 1992;263: 668-681.
44. 3H]ifenprodil binding to σ receptors in rat brain. Eur J Pharmacol. 1993;236:159-163.
45. Lyengar S, Dilworth VM, Mick SJ, Contrras PC, Monahan JB, Rao TS, Wood PL. Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors. Brain Res. 1990;524:322-326.
46. Whittemore ER, Ilyin VI, Woodward RM. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition. J Pharmacol Exp Ther. 1997;282:326-338.